Tech Company Inital Public Offerings
Seer IPO
On 12/3/2020, Seer became a public company.
Transaction Overview
Company Name
Announced On
12/3/2020
Transaction Type
IPO
Amount
$174,800,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:approximately $65.0 million to commercialize our Proteograph Product Suite through our ongoing sales and marketing activities; andthe remainder for other development work associated with advancing our Proteograph Product Suite, research and development, and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Healthcare IT
Mailing Address
3800 Bridge Pkwy. 102
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Overview
Seer (Nasdaq: SEER) is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. We are advancing a portfolio of first-in-class products for research and clinical applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Omid Farokhzad
President
Philip Ma
Vice President
Asim Siddiqui
VP - Engineering
Gregory Troiano
VP - Product Management
William Manning
VP - R & D
John Blume
Browse more venture capital transactions:
Prev: 12/3/2020: Actasys venture capital transaction
Next: 12/3/2020: Step Mobile venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs